Venus Concept Stock (NASDAQ:VERO)
Previous Close
$0.30
52W Range
$0.25 - $12.93
50D Avg
$0.59
200D Avg
$1.82
Market Cap
$578.19K
Avg Vol (3M)
$6.41M
Beta
-0.06
Div Yield
-
VERO Company Profile
Venus Concept Inc. is a medical technology firm that specializes in offering a range of innovative minimally and non-invasive solutions for medical aesthetics and hair restoration. Operating both domestically in the U.S. and internationally, the company is responsible for the development, market introduction, and ongoing provision of these advanced technologies and associated services. Its comprehensive product lineup features several cutting-edge devices: Venus Legacy: A non-invasive system primarily used in dermatological and general surgical procedures for female patients. Venus Versa: A versatile, multi-application platform designed for various aesthetic and cosmetic treatments. Venus Viva: A portable and advanced fractional radiofrequency (RF) system utilized in dermatological procedures for skin ablation and resurfacing. Venus Fiore: Employs non-thermal RF technology, combined with massage and magnetic field pulses, to address a variety of medical conditions. Venus Bliss: Targets non-invasive lipolysis of the abdomen and flanks, suitable for individuals with a body mass index (BMI) of 30 or below. Venus Glow: A specialized dermabrasion device aimed at enhancing overall skin appearance. NeoGraft: Provides advanced hair restoration using an automated Follicular Unit Extraction (FUE) and implantation system. Venus Velocity & Venus Epileve: These devices facilitate permanent hair removal, reduction, and the treatment of pseudofolliculitis barbae. ARTAS iX: A robotic system that assists physicians during hair transplantation by automating the identification, extraction, and implantation of follicular units from the scalp, as well as the creation of recipient sites. The company's corporate headquarters are located in Toronto, Canada.